MMP9 and neoplasm: The results demonstrated that MCMD NPs enhance drug accumulation in tumors and release DOX after the enzymatic degradation of matrix metalloproteinase-9 (MMP9) in the TME, thereby enhancing the direct cytotoxic effect of DOX on tumor cells (Figure 13).